Jonathan Weissman

Jonathan S Weissman, Ph.D. joined 5AM Ventures in 2018 as a Venture Advisor. He is Landon T Clay Professor at the Whitehead Institute, a Professor of Biology at MIT, and an Investigator of the Howard Hughes Medical Institute. He is a cofounder (with Jennifer Doudna) and serves as the head of the scientific advisory board for the Innovative Genomics Institute (IGI) of Berkeley and UCSF. He also serves on the Scientific Advisory Board for the Stowers Institute (as Chairman), Amgen, Tessera Therapeutics, Tenaya Therapeutics, and the Helen Hay Whitney Foundation. Additionally, Dr. Weissman is a co-founder of KSQ Therapeutics and Maze Therapeutics. He has received the Irving Sigal Young Investigator Award from the Protein Society, the Raymond and Beverly Sackler International Prize in Biophysics, the National Academy of Sciences Award for Scientific Discovery, and the Keith R. Porter Lecture Award from the American Society for Cell Biology. Dr. Weissman is a member of the National Academy of Sciences. He received his A.B. in Physics summa cum laude from Harvard College. After obtaining a Ph.D. in Physics from the Massachusetts Institute of Technology, where he worked with Dr. Peter Kim, he pursued his postdoctoral fellowship training in Arthur Horwich’s laboratory at Yale University School of Medicine, then was recruited as faculty to UCSF in 1996, and became co-Vice Chair of the department of Cellular and Molecular Pharmacology for 10 years until he joined the Whitehead Institute in May 2020. Dr. Weissman is now based in the Boston office.